SEC Form D filing
Claris Biotherapeutics, Inc.
Biotech · Series A · Regulation D 506(b) · NJ · Filed March 7, 2025
Offering amount
$3.3M
Exemption
Reg D 506(b)
Issuer state
NJ
Filing date
March 7, 2025
Signature date
—
CIK
0001809726
Summary
$3.3M offering for biotherapeutics company; early-stage biotech.
Source
FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.